We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.25 | -0.63% | 39.20 | 107,528 | 13:36:36 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 39.00 | 39.95 | 39.20 | 38.50 | 38.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 226.47 | 207.96M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 13:36:37 | O | 7,518 | 39.38 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 01/12/2023 | 12:23 | UKREG | Alliance Pharma PLC Total Voting Rights |
| 09/11/2023 | 11:17 | UKREG | Alliance Pharma PLC Notification of Major Holdings |
| 07/11/2023 | 07:00 | UKREG | Alliance Pharma PLC Appointment of Non-Executive Directors |
| 01/11/2023 | 12:50 | UKREG | Alliance Pharma PLC Total Voting Rights |
| 16/10/2023 | 17:13 | UKREG | Alliance Pharma PLC Director Dealings |
| 12/10/2023 | 13:51 | UKREG | Alliance Pharma PLC Notification of Major Interest in Shares |
| 05/10/2023 | 15:39 | UKREG | Alliance Pharma PLC Grant of Options to Directors |
| 02/10/2023 | 14:14 | UKREG | Alliance Pharma PLC Total Voting Rights |
| 29/9/2023 | 11:38 | UKREG | Alliance Pharma PLC Notification of Major Holdings |
| 26/9/2023 | 10:53 | ALNC |  Alliance Pharma first half profit plunges, stops dividend payout |
Alliance Pharma (APH) Share Charts1 Year Alliance Pharma Chart |
|
1 Month Alliance Pharma Chart |
Intraday Alliance Pharma Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 03/12/2023 | 23:34 | Alliance Pharma pays Dividends | 2,175 |
| 21/8/2018 | 16:36 | A Canadian Stock Worth Watching | 1 |
| 11/6/2018 | 09:21 | Unexpected | - |
| 07/11/2016 | 15:35 | Alliance Pharma plc | 1 |
| 15/7/2013 | 09:15 | ALLIANCE PHARMA – 2005 Strong Riser | 611 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 13:36:38 | 39.38 | 7,518 | 2,960.59 | O |
| 13:24:08 | 39.22 | 609 | 238.84 | O |
| 13:09:54 | 39.20 | 43 | 16.86 | AT |
| 13:09:54 | 39.20 | 1,768 | 693.06 | AT |
| 13:09:51 | 39.20 | 747 | 292.82 | AT |
| Top Posts |
|---|
Posted at 04/12/2023 08:20 by Alliance Pharma Daily Update Alliance Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker APH. The last closing price for Alliance Pharma was 39.45p.Alliance Pharma currently has 540,150,223 shares in issue. The market capitalisation of Alliance Pharma is £207,957,836. Alliance Pharma has a price to earnings ratio (PE ratio) of 226.47. This morning APH shares opened at 38.50p |
Posted at 21/11/2023 13:35 by monet Blackhorse Bad move yesterday geeting out of RUA and IKA.RUA up over 120% and IKA 28% IKA Blackhorse2320 Nov '23 - 09:50 - 5136 of 5139 0 0 0 Out with profit & going to buy APH RUA Blackhorse2320 Nov '23 - 11:39 - 3093 of 3140 0 0 0 Money moving to APH |
Posted at 18/11/2023 12:37 by blackhorse23 They got takeaway offer 100p per share last year but rejected as share price valued over 140p , very sure some big PHARMA company will offer again |
Posted at 17/11/2023 10:18 by blackhorse23 Good dividends yield & profitable healthcare stocks , group received takeover offer last year 100p per share & corporate shareholders rejected that offer & believe share price valuation more than 100p per share . Coming this microeconomic APH will be one of most profitable stocks in LSE with low value share price . So bounce back is coming |
Posted at 07/11/2023 11:03 by seagreen added another small long to my ISA ...I find the fundamentals for a slow share price rather compelling....even makes real money...hey ho ...good new non execs who know the e commerce distribution channels ...opening up in Canada...looking forward to the finals in 2024 there seems no reason that they will not be significantly better~But WTF do I know |
Posted at 14/10/2023 10:24 by tomzimerman The main factors that determine whether a share price moves up or down are supply and demand. Essentially, if more people want to buy a share than sell it, the price will rise because the share is more sought-after (the 'demand' outstrips the 'supply'). On the other hand, if supply is greater than demand, then the price will fall. |
Posted at 05/10/2023 17:46 by cisk Well, I hope getting the share price over £1 is in their targets:Peter Butterfield, Chief Executive Officer, has been awarded 851,666 share options. Andrew Franklin, Chief Financial Officer, has been awarded 568,866 share options. Jeyan Heper, Chief Operating Officer, has been awarded 861,111 share options (250,000 of which have been awarded pursuant to his joining of the Company earlier this year). The awards have been granted at nil-cost and become exercisable on 4 October 2026 subject always to continued employment and the satisfaction of performance conditions based on EPS, TSR and ROCE targets. The net effect of the grant of Share Options and the resultant option holdings are shown in the table below: Name Share Options granted Total no. of options over ordinary shares now held Peter Butterfield 851,666 4,057,553 Andrew Franklin 568,866 2,845,373 Jeyan Heper 861,111 861,111 |
Posted at 04/10/2023 10:24 by tomzimerman Come to the conclusion this is a parody account, no one can be that stupid consistently and ignore the share price and constant decline here. Sincerely hope it goes north from here for those genuine investors but have to point out your comments are completely wrong and misleading to anyone reading them. |
Posted at 29/9/2023 07:12 by tomzimerman Watch the share price today |
Posted at 30/8/2023 21:25 by blackhorse23 when big buyers ready to invest & buy stocks & share price goes blue , ITS POSITIVE. This is dividend stocks , high dividend yields. At this price if buyers hold for few years , will get all money back FROM DIVIDENDS , meantime share price will be 10 times MULTI BAG ... that's the goal of those institutional investors |
Posted at 19/8/2023 21:40 by dartron Strange that you didn't use the latest trading update. I have provided the pertinent part for you. Released 18th July 2023."Free cash flow in the Period was £5.7m higher than the prior period at £10.8m (H1 22: £5.1m) and net debt decreased £7.5m to £94.5m at 30 June 2023 (31 December 2022: £102.0m)" My opinion here is that, Investors are not selling, the price drops are due to aggressive shorting, trying to cover back the stock that the directors bought (100k), and Dbay have taken (1%). - Andrew Franklin, the Chief Financial Officer of the Company, purchased 50,988 ordinary shares - LeCouilliard, the non-executive Chair of the Company, purchased 40,957 ordinary shares - DBAY Advisors Limited as discretionary investment manager of Fixtaia Limited, Logistics Development Group Plc and DouglasBay Capital IV Fund LP, purchased 5.4M by Aug 11th Anyone who was concerned about debt and court cases would have sold up months ago. Short started in May. Its accumulation time, but each to their own. Court case is done, its only an appeal over the fine, which is a max of 7.9m. So guess already baked in to the price. Expect shorters are hoping to exploit the RNS if the appeal fails (Which I think it will fail). One party did not even appeal, sounds banged to rights! (I'm future looking here, they pay the fine and get on with it). Butterfield may still get disqualified, again not my concern. If the CFO is happy to buy 50k shares, it tells me they can navigate this. Maybe they know that they got off lightly! 7.9M is manageable for them to pay I think, even if it is at the expense of the interim dividend. (From IC) "Shareholders will take heart from the news that the board has addressed the day-to-day management issue by appointing Jeyan Heper in the newly created post of chief operating officer. Mr Heper is a management veteran who has served in senior positions at Proctor & Gamble, Danone and British American Tobacco." (IC comment) "Broker Numis forecasts a 2023 price/earnings ratio of 11 for 2023 and expects Alliance to focus on higher-growth ecommerce in the US. That could mean the shares are priced for recovery, but we remain cautious." From the government press release Feb 2022: "Alliance Pharmaceuticals Limited and Alliance Pharma plc are jointly and severally liable for £7,900,000" The appeal has already been heard: Appeal and the competition law issue of the director disqualification proceedings to be heard before the Competition Appeal Tribunal between 5 and 27 June and 27 July and 4 August: Schedule here No publicised outcome yet, though Dbay bought a further 1% after this date (11th Aug). They are pretty smart, don't know if public could attend? All to play for I think, happy to hold a few under 50p. Short has to cover doesn't it. This could get taken out for twice the current share price IMO. I hope I have answered the court case questions, which to be fair could have been googled in 30 seconds. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
